New research on Colombian-grown cannabis reveals “significant phytochemical diversity” in the plants, uncovering what authors say are “four distinct chemotypes based on cannabinoid profile” as well as plants that are rich in uncommon terpenes.

The diversity in compounds produced by Colombian cannabis plants could benefit not only growers—for example, by increasing resistance to pests and other pathogens—but also the development of unique medical marijuana products, says the study, published in the journal Phytochemical Analysis.

Read the full article HERE.